Dapagliflozin (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dapagliflozin" in Italian language version.

refsWebsite

Global rank Italian rank

2web.archive.org

1^st place

1^st place

799^th place

22^nd place

2^nd place

7^th place

4^th place

9^th place

195^th place

342^nd place

1astrazeneca.com

low place

low place

493^rd place

15^th place

68^th place

57^th place

ansa.it

Cardiologi, bene ok Aifa a terapia rivoluzionaria scompenso - Salute & Benessere, su ANSA.it, 16 gennaio 2022. URL consultato il 18 gennaio 2022.

astrazeneca.com

(EN) AstraZeneca - FORXIGA (dapagliflozin) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes, su astrazeneca.com.

doi.org

dx.doi.org

(ES) Pérez López G, González Albarrán O, Cano Megías M, [Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus], in Nefrologia, vol. 30, n. 6, 2010, pp. 618–25, DOI:10.3265/Nefrologia.pre2010.Sep.10494, PMID 21113210.

europa.eu

ema.europa.eu

Forxiga, su European Medicines Agency, 17 settembre 2018. URL consultato il 1º settembre 2022.

nih.gov

ncbi.nlm.nih.gov

(ES) Pérez López G, González Albarrán O, Cano Megías M, [Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus], in Nefrologia, vol. 30, n. 6, 2010, pp. 618–25, DOI:10.3265/Nefrologia.pre2010.Sep.10494, PMID 21113210.

oadoi.org

(ES) Pérez López G, González Albarrán O, Cano Megías M, [Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus], in Nefrologia, vol. 30, n. 6, 2010, pp. 618–25, DOI:10.3265/Nefrologia.pre2010.Sep.10494, PMID 21113210.

web.archive.org

(EN) www.ama-assn.org (PDF), su ama-assn.org (archiviato dall'url originale il 7 febbraio 2012).
Bristol-Myers Squibb, su ctr.bms.com (archiviato dall'url originale l'8 luglio 2011).

who.int

apps.who.int

WHO Model List of Essential Medicines – 22nd List (2021), su apps.who.int.